VLVbio Competitors and Similar CompaniesClear all
VLVbio's competitors and similar companies include 3D Medicines and Stratify Genomics.
 VLVbio VLVbio is a company devoted to the invention and development of PEVIVA Keratin 18 biomarkers M30 and M65 for the measurement of epithelial cell death in liver disease and oncology. |  3D Medicines 3D Medicines (思路迪, 3DMed) is a commercial-stage biopharmaceutical company that develops differentiated next-generation immuno-oncology drugs. |  Stratify Genomics Stratify Genomics' flagship test, Prompt, evaluates a man’s genetic predisposition to prostate cancer. | |
Founding Date | Founding Date 2013 | Founding Date 2010 | Founding Date N/A |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations HQ | Locations Shanghai, CN HQ Singapore, SG Dubai, AE Fremont, US | Locations San Diego, US HQ |
Employees | Employees 9 | Employees 70030% decrease | Employees 5 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 140m (over 5 years ago) | Latest funding round $ 2.2m (almost 7 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 281m | Total funding raised $ 2.2m |
For sources of this data, please see the company profile
View Company Profiles
3D Medicines
HQ
Shanghai, CN
Employees
700↓ 30% decrease
3D Medicines (思路迪, 3DMed) is a commercial-stage biopharmaceutical company that develops differentiated next-generation immuno-oncology drugs.
View companyStratify Genomics
HQ
San Diego, US
Employees
5
Stratify Genomics' flagship test, Prompt, evaluates a man’s genetic predisposition to prostate cancer.
View company